Ejandra, Fabian L.

HRN: 28-82-01  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/23/2025
10/04/2025
IV
2.25g
Q6h
Infected Wound
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines